Psychopharmacology in children with intellectual disability

Advances in Psychiatric Treatment

Volumn 17, Issue 1, 2011, Pages 32-40

  Bramble, David ^a  

^a Telford and Wrekin PCT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; ATOMOXETINE; CARBAMAZEPINE; CITALOPRAM; CLOMIPRAMINE; CLONIDINE; DEXAMPHETAMINE; DIAZEPAM; FLUOXETINE; LITHIUM CARBONATE; LORAZEPAM; MELATONIN; METHYLPHENIDATE; OLANZAPINE; RISPERIDONE; SERTRALINE; VALPROIC ACID; ZALEPLON; ZOLPIDEM; ZOPICLONE;

AGITATION; ARTICLE; ATTENTION DEFICIT DISORDER; AUTISM; BEDTIME DOSAGE; BIPOLAR DISORDER; CHILD; COMORBIDITY; CONDUCT DISORDER; DRUG EFFICACY; DRUG TOLERABILITY; FEEDING DISORDER; GASTROINTESTINAL SYMPTOM; GENERALIZED ANXIETY DISORDER; HUMAN; INFORMED CONSENT; INSOMNIA; INTELLECTUAL IMPAIRMENT; INTERMITTENT EXPLOSIVE DISORDER; LONG TERM CARE; MAJOR DEPRESSION; OBSESSION; OBSESSIVE COMPULSIVE DISORDER; PANIC; PATIENT COMPLIANCE; PHOBIA; POLYPHARMACY; PRACTICE GUIDELINE; PSYCHOPHARMACOLOGY; SCHIZOPHRENIA; SEDATION; SIDE EFFECT; SLEEP DISORDER;

EID: 78651519829     PISSN: 13555146     EISSN: None     Source Type: Journal    
DOI: 10.1192/apt.bp.108.005587     Document Type: Article

References (31)

1. Aman M, Buican B, Arnold L (2003) Methylphenidate treatment in children with borderline IQ and mental retardation: Analysis of three aggregated studies. Journal of Child and Adolescent Psychopharmacology 13: 27-38.
2. Armenteros J (1997) Risperidone in adolescents with schizophrenia. Journal of the American Academy of Child and Adolescent Psychiatry 36: 694-700.
3. Arnold L, Aman M, Cook A (2006) Atomoxetine for hyperactivity in autistic spectrum disorder: A placebo-controlled crossover trial. Journal of the American Academy of Child and Adolescent Psychiatry 45: 1196-205.
4. Benson B, Brooks W (2008) Aggressive challenging behaviour and intellectual disability. Current Opinion in Psychiatry 21: 454-8.
5. Bernard S, Turk J (eds) (2009) Medical. In Developing Mental Health Services for Children and Adolescents with Learning Disabilities: A Toolkit for Clinicians: 42-8. RCPsych Publications.
6. Besag F (2004) Behavioural effects of the newer antiepileptic drugs. Expert Opinion on Drug Safety 3: 1-8.
7. Bramble D, Feehan C (2005) Psychiatrists' use of melatonin with children. Child and Adolescent Mental Health 10: 145-9.
8. Bramble D (2007) Prescribing practices in British child psychiatrists for children with learning disabilities. Journal of Psychopharmacology 21: 486-91.
9. British Medical Association, Royal Pharmaceutical Society of Great Britain, Royal College of Paediatrics and Child Health, et al (2009) Section 4.2: Drugs used in psychosis and related disorders. In British National Formulary for Children (2010-2011). Pharmaceutical Press.
10. Conners CK (1997) Conners Rating Scales - Revised. Multi-Health Systems.
11. Danielyan A, Kowatch R (2005) Management options for bipolar disorder in children and adolescents. Paediatric Drugs 7: 277-94. (Pubitemid 41455885)
12. De Leersnyder H, de Blois M, Vekemans M, et al (2001) Beta (1)-adrenergic antagonists improve sleep and behavioural disturbances in a circadian disorder, Smith-Magenis syndrome. Journal of Medical Genetics 38: 586-90.
13. Emerson E (2003) Prevalence of psychiatric disorders in children and adolescents with and without intellectual disability. Journal of Intellectual Disability Research 47: 51-8.
14. Erickson C, Posey D, Stigler K, et al (2007) Pharmacologic treatment of autism and related disorders. Pediatric Annals 36: 575-85.
15. Garber H (1992) Clomipramine treatment of stereotypic behaviors and self-injury in patients with developmental disabilities. Journal of the American Academy of Child and Adolescent Psychiatry 31: 1157-60.
16. Ingrassia A, Turk J (2005) The use of clonidine for severe and intractable sleep problems in children with neurodevelopmental disorders: A case series. European Child and Adolescent Psychiatry 14: 34-40.
17. King B, Hollander E, Sikich L, et al (2009) Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: Citalopram ineffective in children with autism. Archives of General Psychiatry 66: 583-90.
18. McCracken J, McGough J, Shah B, et al (2002) Risperidone in children with autism and serious behavioural problems. New England Journal of Medicine 347: 314-21.
19. Myers S, Johnson C (2007) Management of children with autism spectrum disorders. Pediatrics 120: 1162-82. (Pubitemid 350085560)
20. National Collaborating Centre for Mental Health (2008) Attention Deficit Hyperactivity Disorder. The NICE Guideline on Diagnosis and Management of ADHD in Children, Young People and Adults. British Psychological Society, Royal College of Psychiatrists (http://www.nice.org.uk/nicemedia/live/12061/42060/ 42060.pdf).
21. Pandina G, Aman M, Findling R (2006) Risperidone in the management of disruptive behaviour disorders. Journal of Child and Adolescent Psychopharmacology 16: 379-92.
22. Pearson D, Lane D, Santos C, et al (2004) Effects of methylphenidate treatment in children with mental retardation and ADHD: Individual variation in medication response. Journal of the American Academy of Child and Adolescent Psychiatry 43: 686-98. (Pubitemid 38858640)
23. Ramchandani P, Wiggs L, Webb V, et al (2000) A systematic review of settling and night waking problems in children. BMJ 520: 209-13.
24. Ratey J, Sovner R, Parks J, et al (1991) Buspirone treatment of aggression and anxiety in mentally retarded patients: A multiple-baseline, placebo lead-in study. Journal of Clinical Psychiatry 52: 159-62.
25. Reiss S, Levitan G, Szysko J (1982) Emotional disturbance and mental retardation: Diagnostic overshadowing. American Journal of Mental Deficiency 86: 567-74.
26. Santosh P, Baird G (1999) Psychopharmacology in children and adults with intellectual disability. Lancet 354: 233-43.
27. Santosh P, Baird G, Pityaratstian N, et al (2006) Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: A retrospective and prospective effectiveness study. Child: Care, Health and Development 32: 575-83.
28. Simonoff E, Stores G (1987) Controlled trial of trimeprazine tartrate for night waking. Archives of Diseases of Childhood 62: 253-7.
29. Turk J (2003) Melatonin supplementation for severe and intractable sleep disturbance in young people with developmental disabilities: Short review and commentary. Journal of Medical Genetics 40: 793-6.
30. Unwin G, Deb S (2006) Your Guide to Taking Medicine for Behaviour Problems: Easy Read. University of Birmingham (http://www.ld-medication.bham.ac. uk/2erg.pdf). Also available in audio format as an MP3 download.
31. US Food and Drug Administration (2006) FDA approves the first drug to treat irritability associated with autism, risperidal. FDA (http://www.fda.gov/ NewsEvents/Newsroom/PressAnnouncements/2006/ucm108759.htm).